David Adler

Professor David Adler is a senior oncology drug development and translational medicine leader with more than 15 years of experience spanning pharmaceutical development and academic cancer research. He spent a decade in senior medical and clinical development leadership roles within Bayer AG’s Global Oncology Clinical Development organization and currently serves as Chief Scientific & Medical Officer at the PATHORA Institute of Pathology & Tissue Medicine. He also holds academic appointments at the Hebrew University of Jerusalem, Ben-Gurion University of the Negev, and the University of Bonn.